Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
ATI PHYSICAL THERAPY Aktie jetzt für 0€ handeln | |||||
Di | ATI Physical Therapy, Inc. - 8-K, Current Report | - | SEC Filings | ||
04.12. | NSE - ATI Physical Therapy, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | - | SEC Filings | ||
03.12. | ATI Physical Therapy receives delisting notice from NYSE | 2 | Seeking Alpha | ||
03.12. | ATI Physical Therapy wechselt an den OTC Pink Market | 2 | Investing.com Deutsch | ||
03.12. | ATI Physical Therapy to shift stock to OTC Pink Market | 6 | Investing.com | ||
03.12. | NYSE to Commence Delisting Proceedings Against ATI Physical Therapy, Inc. (ATIP) | 73 | Business Wire | NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange ("NYSE", the "Exchange") announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the Class A common... ► Artikel lesen | |
03.12. | ATI Physical Therapy, Inc. - 8-K, Current Report | - | SEC Filings | ||
05.11. | Earnings call: ATI Physical Therapy reports growth amid market challenges | 1 | Investing.com | ||
05.11. | ATI Physical Therapy verzeichnet Wachstum trotz Marktherausforderungen | 1 | Investing.com Deutsch | ||
04.11. | ATI Physical Therapy Reports Third Quarter 2024 Results | 40 | PR Newswire | BOLINGBROOK, Ill., Nov. 4, 2024 /PRNewswire/ -- ATI Physical Therapy, Inc. (NYSE: ATIP) ("ATI" or the "Company"), a nationally recognized outpatient physical... ► Artikel lesen | |
04.11. | ATI Physical Therapy, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
03.10. | ATI Physical Therapy Issues $10.5 Million in New Second Lien PIK Notes | 1 | Investing.com | ||
02.10. | ATI Physical Therapy, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
12.08. | Earnings call: ATI Physical Therapy sees growth and improved margins in Q2 | 1 | Investing.com | ||
05.08. | ATI Physical Therapy, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
05.08. | ATI Physical Therapy, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
05.08. | ATI Physical Therapy Reports Second Quarter 2024 Results | 81 | PR Newswire | Drove Continued Growth in Visits, Rate per Visit, Revenue and Adjusted EBITDA
Advanced Company's Capacity to Expand Patient Access to High-Quality Care
BOLINGBROOK, Ill., Aug. 5, 2024 /PRNewswire/... ► Artikel lesen | |
06.05. | ATI Physical Therapy Reports First Quarter 2024 Results | 89 | PR Newswire | Disciplined Execution of Clinic Operations Drove Continued Growth
People Strategies and Culture Refresh Efforts Result in Exceptional Therapist Retention
BOLINGBROOK, Ill., May 6, 2024 /PRNewswire/... ► Artikel lesen | |
26.02. | ATI Physical Therapy Reports Fourth Quarter and Full Year 2023 Results | 192 | PR Newswire | Refreshed Corporate Leadership and Dedicated Field Team Expand Patient Access, Drove Sequential Growth every Quarter in Topline Revenue and Visits per Day
Accelerated Execution of Clinic Operations... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
LIFEMD | 5,040 | 0,00 % | LifeMD, Inc.: LifeMD Reports Third Quarter 2024 Results | Total revenues increased 38% year-over-year to $53.4 million with telehealth revenue up 65%Record gross margin of 90.6%, up 300 basis points from the year-ago periodAdjusted EBITDA increased 33% to... ► Artikel lesen | |
TEMPUS AI | 35,500 | 0,00 % | Tempus AI's (TEM) AI-Powered Healthcare Revolution: What's Next? | ||
FRESENIUS | 33,120 | -0,24 % | Fresenius SE Aktie: Positiver Umsatztrend! | Die Fresenius SE-Aktie zeigt sich im aktuellen Handelsverlauf an der XETRA mit wechselhafter Tendenz. Nach einem Handelsstart bei 34,92 EUR bewegte sich der Kurs im Tagesverlauf zwischen verschiedenen... ► Artikel lesen | |
GERRESHEIMER | 69,40 | +2,59 % | EQS-News: Gerresheimer AG: FDA erteilt "Tentative Approval" für Lasix von SQ Innovation® ONYU* | EQS-News: Gerresheimer AG
/ Schlagwort(e): Sonstiges/Zulassungsantrag
Gerresheimer: FDA erteilt "Tentative Approval" für Lasix von SQ Innovation® ONYU*
16.12.2024 / 09:00... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 51,80 | -0,58 % | Siemens Healthineers: Mögliche Luft nach oben | Am 6. Februar stehen bei Siemens Healthineers die Zahlen zum ersten Quartal an. Der Jahresauftakt dürfte nicht berauschend verlaufen, ein ruhiges Startquartal wird von den Experten von Jefferies erwartet.... ► Artikel lesen | |
BRIGHTSPRING HEALTH SERVICES | 17,260 | 0,00 % | BrightSpring Health Services, Inc. Reports Third Quarter 2024 Financial Results and Increases Full Year 2024 Guidance | LOUISVILLE, Ky., Nov. 01, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
PROGYNY | 14,350 | 0,00 % | Progyny, Inc. Announces Third Quarter 2024 Results | Sales Season Yields Over 80 New Clients, 1.1 Million New Covered LivesSelected by a Leading National Health Plan and a Regional Health Plan as Their Preferred Partner1.5 Million Lives Adopt Newest... ► Artikel lesen | |
RXSIGHT | 33,650 | 0,00 % | RxSight cut to hold at Stifel on competition concerns | ||
FRESENIUS MEDICAL CARE | 44,140 | +0,59 % | WARBURG RESEARCH stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Sell' | HAMBURG (dpa-AFX Analyser) - Das Analysehaus Warburg Research hat das Kursziel für FMC von 31 auf 36 Euro angehoben, aber die Einstufung auf "Sell" belassen. Einsparungen trieben die Marge des Dialysespezialisten... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 81,25 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance | SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
ADAPTHEALTH | 10,305 | 0,00 % | AdaptHealth Corp. Announces Third Quarter 2024 Results | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen | |
GENEDX | 77,33 | 0,00 % | GeneDx Reports Third Quarter 2024 Financial Results and Business Highlights | STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today reported its financial results for the third... ► Artikel lesen | |
NANO-X IMAGING | 6,770 | 0,00 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication | Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared indication... ► Artikel lesen | |
CLEARPOINT NEURO | 15,545 | 0,00 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain | Only Device Approved to Deliver First Disease-Modifying Treatment for AADC Deficiency in the United StatesSOLANA BEACH, CA / ACCESSWIRE / November 13, 2024 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the... ► Artikel lesen | |
ALIGNMENT HEALTHCARE | 10,610 | 0,00 % | Alignment Healthcare Reports Third Quarter 2024 Results | Reports $692.4 million in total revenue, up 51.6% year-over-year Increases Medicare Advantage membership, up 57.7% year-over-year to approximately 182,300 members, beating third-quarter and year-end... ► Artikel lesen |